One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Contemporary Management of Severe Symptomatic Aortic Stenosis
MarcEugèneMDabPiotrDuchnowskiMDcBernardPrendergastMD, PhDdOlafWendlerMDeCécileLarochefJean-LucMoninMD, PhDgYannickJobicMDhBogdan A.PopescuMD, PhDiJeroen J.BaxMD, PhDjAlecVahanianMDbBernardIungMDab
doi : 10.1016/j.jacc.2021.09.864
Volume 78, Issue 22, 30 November 2021, Pages 2131-2143
There were gaps between guidelines and practice when surgery was the only treatment for aortic stenosis (AS).
Referral for Intervention in Severe Symptomatic Aortic Stenosis: Some Progress But Further Room for Improvement?
Patrick T.O’GaraMDYee-PingSunMDSiddharth M.PatelMD
doi : 10.1016/j.jacc.2021.09.865
Volume 78, Issue 22, 30 November 2021, Pages 2144-2146
Life Expectancy After Surgical Aortic Valve Replacement
AndreasMartinssonMD, PhDabSusanne J.NielsenPhDbcMilanMilojevicMD, PhDdeBjörnRedforsMD, PhDabElmirOmerovicMD, PhDabTheisTønnessenMD, PhDfgTomasGudbjartssonMD, PhDhiGöranDellgrenMD, PhDbcAndersJeppssonMD, PhDbc
doi : 10.1016/j.jacc.2021.09.861
Volume 78, Issue 22, 30 November 2021, Pages 2147-2157
Surgical risk, age, perceived life expectancy, and valve durability influence the choice between surgical aortic valve replacement (SAVR) and transcatheter aortic valve implantation. The contemporaneous life expectancy after SAVR, in relation to surgical risk and age, is unknown.
Can TAVR Match the Excellent Survival After SAVR in Younger, Low-Risk Patients??
NatalieGlaserMD, PhD
doi : 10.1016/j.jacc.2021.09.860
Volume 78, Issue 22, 30 November 2021, Pages 2158-2160
Trends in Transcatheter and Surgical Aortic Valve Replacement Among Older Adults in the United States
MakotoMoriMDab?AakritiGuptaMD, MSbc?YunWangPhDbdTorstenVahlMDcTamimNazifMDcAjay J.KirtaneMD, SMcIsaacGeorgeMDeCelina M.YongMD, MBA, MScfgOyereOnumaMD, MSchSusheelKodaliMDcArnarGeirssonMDaMartin B.LeonMDcHarlan M.KrumholzMD, SMbij
doi : 10.1016/j.jacc.2021.09.855
Volume 78, Issue 22, 30 November 2021, Pages 2161-2172
Recent trends, including survival beyond 30 days, in aortic valve replacement (AVR) following the expansion of indications for transcatheter aortic valve replacement (TAVR) are not well-understood.
Aortic Valve Replacement and Patient-Centered Implementation: To Boldly Go Where No Device Has Gone Before?
SreekanthVemulapalliMDabcVinod H.ThouraniMDd
doi : 10.1016/j.jacc.2021.09.856
Volume 78, Issue 22, 30 November 2021, Pages 2173-2176
Assessing Cardiac Amyloidosis Subtypes by Unsupervised Phenotype Clustering Analysis
LouisBonnefousPhDabcdMouniraKharoubiPhD (c)bcdeMélanieBézardPhD (c)bcdeSilviaOghinaMDbcdeFabienLe BrasMDbcfElsaPoullotMDbgValérieMolinier-FrenkelMD, PhDbdgPascaleFanenMD, PhDbdhJean-FrançoisDeuxMD, PhDbcdiVincentAudardMD, PhDbcdjEmmanuelIttiMD, PhDbcdkThibaudDamyMD, PhDbcdel?EtienneAudureauMD, PhDad?
doi : 10.1016/j.jacc.2021.09.858
Volume 78, Issue 22, 30 November 2021, Pages 2177-2192
Cardiac amyloidosis (CA) is a set of amyloid diseases with usually predominant cardiac symptoms, including light-chain amyloidosis (AL), hereditary variant transthyretin amyloidosis (ATTRv), and wild-type transthyretin amyloidosis (ATTRwt). CA are characterized by high heterogeneity in phenotypes leading to diagnosis delay and worsened outcomes.
Phenotype Mapping in Cardiac Amyloidosis?
Frederick L.RubergMD
doi : 10.1016/j.jacc.2021.09.857
Volume 78, Issue 22, 30 November 2021, Pages 2193-2195
Myocardial Bridging: Diagnosis, Functional Assessment, and Management: JACC State-of-the-Art Review
DavidSternheimMDa?David A.PowerMDa?RajeevSamtaniMDaAnapoornaKiniMDaValentinFusterMD, PhDabSaminSharmaMDa
doi : 10.1016/j.jacc.2021.09.859
Volume 78, Issue 22, 30 November 2021, Pages 2196-2212
Myocardial bridging (MB) is a congenital coronary anomaly in which a segment of the epicardial coronary artery traverses through the myocardium for a portion of its length. The muscle overlying the artery is termed a myocardial bridge, and the intramyocardial segment is referred to as a tunneled artery. MB can occur in any coronary artery, although is most commonly seen in the left anterior descending artery. Although traditionally considered benign in nature, increasing attention is being given to specific subsets of MB associated with ischemic symptomatology. The advent of contemporary functional and anatomic imaging modalities, both invasive and noninvasive, have dramatically improved our understanding of dynamic pathophysiology associated with MBs. This review provides a contemporary overview of epidemiology, pathobiology, diagnosis, functional assessment, and management of MBs.
Hospital-Level Percutaneous Coronary Intervention Performance With Simulated Risk Avoidance
Ashwin S.NathanMD, MSabcdPratikManandharMSeDanielWojdylaPhDeAdamNelsonMBBS, PhDePaul N.FiorilliMDabcdStephenWaldoMDfghRobert W.YehMD, MScijSunil V.RaoMDekAlexander C.FanaroffMD, MHSabcPeter W.GroeneveldMD, MSbcTracy Y.WangMD, MScekJayGiriMD, MPHabce
doi : 10.1016/j.jacc.2021.09.862
Volume 78, Issue 22, 30 November 2021, Pages 2213-2217
2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Writing Committee Members?MarthaGulatiMD, MS, FACC, FAHA(Chair)†Phillip D.LevyMD, MPH, FACC, FAHA(Vice Chair)†DebabrataMukherjeeMD, MS, FACC, FAHA(Vice Chair)†EzraAmsterdamMD, FACC†Deepak L.BhattMD, MPH, FACC, FAHA†Kim K.BirtcherMS, PharmD, AACC‡RonBlanksteinMD, FACC, MSCCT§JackBoydMD†Renee P.Bullock-PalmerMD, FACC, FAHA, FASE, FSCCT†TheresaConejoRN, BSN, FAHA?Deborah B.DiercksMD, MSc, FACC¶FedericoGentileMD, FACC#John P.GreenwoodMBChB, PhD, FSCMR, FACC??Erik P.HessMD, MSc†Steven M.HollenbergMD, FACC, FAHA, FCCP††Wael A.JaberMD, FACC, FASE‡‡HaniJneidMD, FACC, FAHA§§José A.JoglarMD, FAHA, FACC‡David A.MorrowMD, MPH, FACC, FAHA†Robert E.O’ConnorMD, MPH, FAHA†Michael A.RossMD, FACC†Leslee J.ShawPhD, FACC, FAHA, MSCCT†
doi : 10.1016/j.jacc.2021.07.052
Volume 78, Issue 22, 30 November 2021, Pages 2218-2261
This executive summary of the clinical practice guideline for the evaluation and diagnosis of chest pain provides recommendations and algorithms for clinicians to assess and diagnose chest pain in adult patients.
2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Writing Committee Members?MarthaGulatiMD, MS, FACC, FAHA(Chair)†Phillip D.LevyMD, MPH, FACC, FAHA(Vice Chair)†DebabrataMukherjeeMD, MS, FACC, FAHA(Vice Chair)†EzraAmsterdamMD, FACC†Deepak L.BhattMD, MPH, FACC, FAHA†Kim K.BirtcherMS, PharmD, AACC‡RonBlanksteinMD, FACC, MSCCT§JackBoydMD†Renee P.Bullock-PalmerMD, FACC, FAHA, FASE, FSCCT†TheresaConejoRN, BSN, FAHA?Deborah B.DiercksMD, MSc, FACC¶FedericoGentileMD, FACC#John P.GreenwoodMBChB, PhD, FSCMR, FACC??Erik P.HessMD, MSc†Steven M.HollenbergMD, FACC, FAHA, FCCP††Wael A.JaberMD, FACC, FASE‡‡HaniJneidMD, FACC, FAHA§§José A.JoglarMD, FAHA, FACC‡David A.MorrowMD, MPH, FACC, FAHA†Robert E.O’ConnorMD, MPH, FAHA†Michael A.RossMD, FACC†Leslee J.ShawPhD, FACC, FAHA, MSCCT†
doi : 10.1016/j.jacc.2021.07.053
Volume 78, Issue 22, 30 November 2021, Pages e187-e285
This clinical practice guideline for the evaluation and diagnosis of chest pain provides recommendations and algorithms for clinicians to assess and diagnose chest pain in adult patients.
The Evolution of the Quintuple Aim: Health Equity, Health Outcomes, and the Economy
DiptiItchhaporiaMD, FACC(President, American College of Cardiology)
doi : 10.1016/j.jacc.2021.10.018
Volume 78, Issue 22, 30 November 2021, Pages 2262-2264
Heart Failure Biomarker Education: An Unmet Need in Cardiovascular Fellowship Training
Parul U.GandhiMDDonna M.WindishMD, MPH
doi : 10.1016/j.jacc.2021.09.863
Volume 78, Issue 22, 30 November 2021, Pages 2265-2266
